Clearview Wealth Advisors’s GSK GSK Stock Holding History

Clearview Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-343	Closed	-$12.2K	–	327
2023 Q2	$12.2K	Hold	343	–	–	0.01%	338
2023 Q1	$12.2K	Hold	343	–	–	0.01%	335
2022 Q4	$12.1K	Sell	343 -89	-21%	-$2.96K	0.01%	307
2022 Q3	$13K	Hold	432	–	–	0.01%	304
2022 Q2	$24K	Hold	432	–	–	0.02%	255
2022 Q1	$24K	Sell	432 -52	-11%	-$2.82K	0.02%	275
2021 Q4	$27K	Buy	+484	New	+$25.2K	0.02%	295

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clearview Wealth Advisors's GSK Position: Q3 2023 in Review

Clearview Wealth Advisors sold out of GSK (GSK) in Q3 2023, closing a stake of 343 shares — an estimated $12.2K sold.

Clearview Wealth Advisors first reported a position in GSK in Q4 2021 and held it in 7 quarters. The position peaked at $27K in Q4 2021. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

Clearview Wealth Advisors reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
Clearview Wealth Advisors sold 343 GSK shares in Q3 2023, an estimated $12.2K.
Clearview Wealth Advisors first reported a position in GSK in Q4 2021 and held it in 7 quarters.
Clearview Wealth Advisors's GSK position peaked at $27K in Q4 2021.
846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Clearview Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.